Short Interest in Aclarion, Inc. (NASDAQ:ACON) Grows By 487.0%

Aclarion, Inc. (NASDAQ:ACON) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 31,700 shares, a growth of 487.0% from the March 31st total of 5,400 shares. Based on an average trading volume of 207,600 shares, the short-interest ratio is currently 0.2 days. Approximately 6.3% of the shares of the company are sold short.

Aclarion Stock Down 8.9 %

Shares of Aclarion stock opened at $6.84 on Tuesday. The business’s fifty day moving average price is $37.82 and its two-hundred day moving average price is $697.02. Aclarion has a 1-year low of $6.80 and a 1-year high of $3,499.51.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.